{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:08:41Z","timestamp":1753891721008,"version":"3.41.2"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T00:00:00Z","timestamp":1669939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To explore the long-term efficacy and safety of dexamethasone treatment <jats:italic>via<\/jats:italic> tympanic antrum catheterization (TAC) in intractable Meniere's disease (MD).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this retrospective analysis, 60 unilateral intractable MD patients treated with TAC in our hospital from January 2020 to August 2020 were followed for 2 years. Fifty patients who underwent endolymphatic sac decompression (ESD) and 50 patients who accepted intratympanic steroids (ITS) were established as the control groups. Vertigo control, hearing level, tinnitus, aural fullness and functional level were assessed during the study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The effective vertigo control rate of intractable MD patients with TAC treatment was 76.7% (46\/60) after 2 years follow-up, with a complete control rate of 58.3% (35\/60) and a substantial control rate of 18.3% (11\/60). The vertigo control rate of TAC was comparable to that of ESD (<jats:italic>\u03c7<\/jats:italic><jats:sup>2<\/jats:sup> = 0.313, <jats:italic>p<\/jats:italic> &amp;gt; 0.05), and significantly higher than that of ITS (<jats:italic>\u03c7<\/jats:italic><jats:sup>2<\/jats:sup> = 4.380, <jats:italic>p<\/jats:italic> &amp;lt; 0.05). The hearing loss rate of these patients was 10.8% (4\/37), which was not significantly different from the control groups (<jats:italic>\u03c7<\/jats:italic><jats:sup>2<\/jats:sup> = 2.452, <jats:italic>p<\/jats:italic> &amp;gt; 0.05). The tinnitus improvement rate of patients with TAC was 56.7% (34\/60), which was significantly higher than that of patients with ESD (<jats:italic>\u03c7<\/jats:italic><jats:sup>2<\/jats:sup> =11.962, <jats:italic>p<\/jats:italic> &amp;lt; 0.001) and ITS (<jats:italic>\u03c7<\/jats:italic><jats:sup>2<\/jats:sup> =15.278, <jats:italic>p<\/jats:italic> &amp;lt; 0.001). The aural fullness improvement rate in the TAC group was 56.7% (34\/60), which was significantly higher than that in the ESD (<jats:italic>\u03c7<\/jats:italic><jats:sup>2<\/jats:sup> = 11.962, <jats:italic>p<\/jats:italic> &amp;lt; 0.001) and ITS groups (<jats:italic>\u03c7<\/jats:italic><jats:sup>2<\/jats:sup> = 5.635, <jats:italic>p<\/jats:italic> &amp;lt; 0.05). The functional level improvement rate in the TAC group was 71.7% (43\/60), which was much higher than that in the ITS group (<jats:italic>\u03c7<\/jats:italic><jats:sup>2<\/jats:sup> = 17.256, <jats:italic>p<\/jats:italic> &amp;lt; 0.001), but there was no significant difference between TAC and ESD (<jats:italic>\u03c7<\/jats:italic><jats:sup>2<\/jats:sup> = 0.410, <jats:italic>p<\/jats:italic> &amp;gt; 0.05). No patients had complications or adverse reactions following TAC treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Dexamethasone treatment <jats:italic>via<\/jats:italic> TAC can effectively control vertigo attacks and improve related symptoms of intractable MD patients, providing valuable new insights into the treatment of MD.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2022.1056724","type":"journal-article","created":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T04:50:03Z","timestamp":1669956603000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Long-term efficacy of dexamethasone treatment via tympanic antrum catheterization for intractable Meniere's disease"],"prefix":"10.3389","volume":"13","author":[{"given":"Yafeng","family":"Lyu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huirong","family":"Jian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yawei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaomin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haibo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daogong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.otc.2010.05.001","article-title":"Current epidemiology of Meniere's syndrome","volume":"43","author":"Alexander","year":"2010","journal-title":"Otolaryngol Clin North Am."},{"key":"B2","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/00129492-200604000-00011","article-title":"Meniere's disease: prevalence of contralateral ear involvement","volume":"27","author":"House","year":"2006","journal-title":"Otol Neurotol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1080\/00016489.2020.1776385","article-title":"Current status on researches of Meniere's disease: a review","volume":"140","author":"Liu","year":"2020","journal-title":"Acta Otolaryngol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"810352","DOI":"10.3389\/fneur.2022.810352","article-title":"A comparison of local endolymphatic sac decompression, endolymphatic mastoid shunt, and wide endolymphatic sac decompression in the treatment of intractable Meniere's disease: a short-term follow-up investigation","volume":"13","author":"Zheng","year":"2022","journal-title":"Front Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2021.10.JNS21145","article-title":"Long-term efficacy of vestibular neurotomy in disabling Meniere's disease and Tumarkin drop attacks","volume":"2022","author":"Veleine","year":"2022","journal-title":"J Neurosurg."},{"key":"B6","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1097\/MAO.0000000000001105","article-title":"Cochlear patency after transmastoid labyrinthectomy for Meniere's syndrome","volume":"37","author":"Sargent","year":"2016","journal-title":"Otol Neurotol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3233\/VES-190682","article-title":"Long-term outcomes of triple semicircular canal plugging for the treatment of intractable Meniere's disease: a single center experience of 361 cases","volume":"29","author":"Zhang","year":"2019","journal-title":"J Vestib Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"3795","DOI":"10.1007\/s00405-022-07374-y","article-title":"Consensus on intratympanic drug delivery for Meniere's disease","volume":"279","author":"Li","year":"2022","journal-title":"Eur Arch Otorhinolaryngol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1097\/MAO.0000000000002563","article-title":"On-demand and low dose intratympanic gentamicin for Meniere's disease: a customized approach","volume":"41","author":"Celis-Aguilar","year":"2020","journal-title":"Otol Neurotol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1097\/00005537-200002010-00009","article-title":"Update on intratympanic gentamicin for Meniere's disease","volume":"110","author":"Blakley","year":"2000","journal-title":"Laryngoscope."},{"key":"B11","doi-asserted-by":"publisher","first-page":"5191","DOI":"10.1007\/s00405-022-07368-w","article-title":"Duration of symptom control following intratympanic dexamethasone injections in Meniere's disease","volume":"279","author":"Hilton","year":"2022","journal-title":"Eur Arch Otorhinolaryngol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"75","DOI":"10.5935\/0946-5448.20220011","article-title":"Treatment of Meniere's disease by multi-session dexamethasone injections","volume":"26","author":"Alsarhan","year":"2022","journal-title":"Int Tinnitus J."},{"key":"B13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/01.mlg.0000245058.11866.15","article-title":"Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy","volume":"117","author":"Haynes","year":"2007","journal-title":"Laryngoscope."},{"key":"B14","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1097\/MAO.0b013e31819bda66","article-title":"Individual differences in the permeability of the round window: evaluating the movement of intratympanic gadolinium into the inner ear","volume":"30","author":"Yoshioka","year":"2009","journal-title":"Otol Neurotol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/VES-150549","article-title":"Diagnostic criteria for Meniere's disease","volume":"25","author":"Lopez-Escamez","year":"2015","journal-title":"J Vestib Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"7212","DOI":"10.1038\/s41598-021-86589-1","article-title":"The relationship between clinical characteristics and magnetic resonance imaging results of Meniere disease: a prospective study","volume":"11","author":"Xie","year":"2021","journal-title":"Sci Rep."},{"key":"B17","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0194-5998(95)70102-8","article-title":"Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere's disease","volume":"113","author":"Inc","year":"1995","journal-title":"Otolaryngol Head Neck Surg"},{"key":"B18","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1037\/t35080-000","article-title":"Balance function test correlates of the Dizziness Handicap Inventory","volume":"2","author":"Jacobson","year":"1991","journal-title":"J Am Acad Audiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/0022-3999(92)90131-K","article-title":"Symptoms, anxiety and handicap in dizzy patients: development of the vertigo symptom scale","volume":"36","author":"Yardley","year":"1992","journal-title":"J Psychosom Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1001\/archotol.1996.01890140029007","article-title":"Development of the tinnitus handicap inventory","volume":"122","author":"Newman","year":"1996","journal-title":"Arch Otolaryngol Head Neck Surg."},{"key":"B21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/000164800454107","article-title":"Effects of middle ear pressure changes on clinical symptoms in patients with Meniere's disease\u2013a clinical multicentre placebo-controlled study","volume":"543","author":"Odkvist","year":"2000","journal-title":"Acta Otolaryngol Suppl."},{"key":"B22","doi-asserted-by":"publisher","first-page":"3097436","DOI":"10.1155\/2022\/3097436","article-title":"Clinical efficacy of retroauricular injection of methylprednisolone sodium succinate in the treatment of sudden deafness with type 2 diabetes","volume":"2022","author":"Zhong","year":"2022","journal-title":"Comput Math Methods Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1097\/00005537-200112000-00003","article-title":"Intratympanic steroid injections for intractable Meniere's disease","volume":"111","author":"Barrs","year":"2001","journal-title":"Laryngoscope."},{"key":"B24","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0378-5955(93)90155-T","article-title":"Osmotic pump implant for chronic infusion of drugs into the inner ear","volume":"70","author":"Brown","year":"1993","journal-title":"Hear Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"827462","DOI":"10.3389\/fneur.2022.827462","article-title":"Efficacy of resection of lateral wall of endolymphatic sac for treatment of Meniere's disease","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Neurol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"103086","DOI":"10.1016\/j.amjoto.2021.103086","article-title":"Intratympanic steroid versus gentamicin for treatment of refractory Meniere's disease: a meta-analysis","volume":"42","author":"Lee","year":"2021","journal-title":"Am J Otolaryngol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.otc.2011.03.004","article-title":"Allergic and immunologic features of Meniere's disease","volume":"44","author":"Derebery","year":"2011","journal-title":"Otolaryngol Clin North Am"},{"key":"B28","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1080\/07315724.2017.1364181","article-title":"Delayed immunomodulatory effect of cow milk-free diet in Meniere's disease","volume":"37","author":"Di Berardino","year":"2018","journal-title":"J Am Coll Nutr."},{"key":"B29","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/MAO.0000000000002467","article-title":"The physiologic role of corticosteroids in Meniere's disease: an update on glucocorticoid-mediated pathophysiology and corticosteroid inner ear distribution","volume":"41","author":"Froehlich","year":"2020","journal-title":"Otol Neurotol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.otohns.2006.03.035","article-title":"Efficacy of steroid injection on idiopathic sudden sensorineural hearing loss","volume":"135","author":"Roebuck","year":"2006","journal-title":"Otolaryngol Head Neck Surg."},{"key":"B31","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S0030-6665(02)00021-X","article-title":"Medical management of Meniere's disease","volume":"35","author":"Sajjadi","year":"2002","journal-title":"Otolaryngol Clin North Am"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.otc.2004.04.004","article-title":"Intratympanic steroids for sensorineural hearing loss","volume":"37","author":"Rauch","year":"2004","journal-title":"Otolaryngol Clin North Am."},{"key":"B33","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/03655230410017599","article-title":"Changes in aquaporin expression in the inner ear of the rat after ip injection of steroids","volume":"553","author":"Fukushima","year":"2004","journal-title":"Acta Otolaryngol Suppl."},{"key":"B34","doi-asserted-by":"publisher","first-page":"140","DOI":"10.2174\/157340611794859334","article-title":"Protective effects of corticosteroids and neurosteroids on cochlear injury","volume":"7","author":"Tabuchi","year":"2011","journal-title":"Med Chem."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.3109\/00016480902791678","article-title":"Meniere's disease and middle ear pressure: vestibular function after transtympanic tube placement","volume":"129","author":"Park","year":"2009","journal-title":"Acta Otolaryngol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.1007\/s00405-014-3428-1","article-title":"Endolymphatic sac surgery vs. tenotomy of the stapedius and tensor tympani muscles in the management of patients with unilateral definite Meniere's disease","volume":"272","author":"Albu","year":"2015","journal-title":"Eur Arch Otorhinolaryngol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1586\/17434440.2.5.533","article-title":"Treatment of Meniere's disease with the low-pressure pulse generator (Meniett device)","volume":"2","author":"Gates","year":"2005","journal-title":"Expert Rev Med Devices."},{"key":"B38","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1080\/00016489.2021.1989485","article-title":"Long-term effect of transtympanic intermittent pressure therapy using a tympanic membrane massage device for intractable meniere's disease and delayed endolymphatic hydrops","volume":"141","author":"Shojaku","year":"2021","journal-title":"Acta Otolaryngol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1001\/archotol.1981.00790410009002","article-title":"Placebo effect in surgery for Meniere's disease. A double-blind, placebo-controlled study on endolymphatic sac shunt surgery","volume":"107","author":"Thomsen","year":"1981","journal-title":"Arch Otolaryngol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/S0140-6736(08)61161-7","article-title":"Meniere's disease","volume":"372","author":"Sajjadi","year":"2008","journal-title":"Lancet."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.1056724\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T04:50:06Z","timestamp":1669956606000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.1056724\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,2]]},"references-count":40,"alternative-id":["10.3389\/fneur.2022.1056724"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2022.1056724","relation":{},"ISSN":["1664-2295"],"issn-type":[{"type":"electronic","value":"1664-2295"}],"subject":[],"published":{"date-parts":[[2022,12,2]]},"article-number":"1056724"}}